Background Banner

Japan Agency for Medical Research and Development

Catalyst Awardee

Novel Molecular Targeted Nucleic Acid Therapy for Liver Fibrosis

KANEYAMA Shuri, PhD | Showa Medical University, Institute for Extracellular Matrix Research; SEIO Koji, PhD
Competition Sponsor: Japan Agency for Medical Research and Development
Awardee Year: 2025  
This project will aim to develop an innovative antisense nucleic acid therapy targeting a novel intracellular adaptor molecule that regulates extracellular matrix


Catalyst Awardee

Development of a new device to facilitate the expansion of stroke rehabilitation opportunities in low and middle income countries using robotic

ARATA Jumpei, PhD| Megwel Co., Ltd. Kyushu University, Faculty of Engineering; MUKAE Nobutaka, MD PhD; MASUDA Mai, M.S.CP; TANABE Tetsuro, BEc; BANDARA D.S.V., PhD; OSAWA Keisuke, PhD; WEIHENG Xue, M. Eng. Competition Sponsor: Japan Agency for Medical Research and Development
Awardee Year: 2025  
Currently, 80% of the medical device



Catalyst Awardee

Research and development of a machine learning model and a self-check application for simple detection of subtle cognitive decline in MCI

KINOSHITA Setsuo, MSc | Medical Solutions Department, Nippontect Systems co.,ltd; SHIGETA Masahiro, MD.PhD
Competition Sponsor: Japan Agency for Medical Research and Development
Awardee Year: 2025  
Dementia is a significant challenge in Japan’s aging society. Early detection of its precursor, mild cognitive impairment (MCI), is crucial as timely intervention can





Sign up for updates